The trajectory of Viagra presents a complex picture for shareholders. While the initial release generated significant gains, the lapse of its intellectual property protection opened the door to generic competitors, https://jemimapupr822476.blogolenta.com/38865916/sildenafil-and-pharma-a-risky-bet